+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neuromodulation Devices Market Size, Share and Trends Analysis Report by Product (Spinal Cord Stimulation, Deep Brain Stimulation), Application (Migraine, Epilepsy), End-use, and Region 2024-2030

  • PDF Icon

    Report

  • 120 Pages
  • September 2024
  • Region: Global
  • Grand View Research
  • ID: 5644957
Description Jump to:
The global neuromodulation devices market size is anticipated to reach USD 10.39 billion by 2030, growing at a CAGR of 10.2% from 2024-2030. The market's growth can be attributed to factors such as rising prevalence of neurological disorders, rising government support to R&D and development of advanced solutions with increased range of applications.

Significant funding from government and private agencies plays a crucial role in advancing the understanding of neurological disorders and improving treatment options. By allocating resources to research initiatives, governments actively facilitate groundbreaking discoveries, encourage technological innovations, and promote the development of more effective neuromodulation technologies. For instance, in August 2024, the Parkinson's Foundation announced an investment of nearly USD 3 million in 33 research grants aimed at advancing the understanding and treatment of Parkinson's disease (PD). This funding will support innovative research projects focusing on various aspects of PD, including its causes, progression, and potential therapies. The grants are part of the Foundation's commitment to fostering scientific advancements that can lead to improved patient outcomes. This financial backing is vital for shaping the treatment landscape for neurological disorders and driving positive changes in patient care.

Furthermore, the increasing accessibility of these advanced devices to patients and healthcare professionals has further increased their adoption. Expanding reimbursement is improving patient access to these advanced therapies. In recent years, healthcare systems have increasingly acknowledged the effectiveness of neuromodulation devices in managing chronic pain, neurological disorders, and various other medical conditions, which has led many healthcare payers to include these devices in their coverage policies. For instance, in February 2024, Nerivio Remote Electrical Neuromodulation (REN) wearable by Theranica became the first non-pharmacological migraine treatment to get commercial coverage in the U.S. from Highmark Inc. The wearable offers acute and preventive treatment options, demonstrating significant clinical benefits in reducing migraine symptoms. Thus, the growing acceptance of neuromodulation therapies among payers is driving market growth.

Neuromodulation Devices Market Report Highlights

  • Based on product, the spinal cord stimulators segment held the largest market share in 2023. This is attributed to the owing to the increasing acceptance of these devices for chronic pain treatment
  • Based on application, the Parkinson’s disease held the largest market share in 2023. This is attributed to the rising prevalence of Parkinson’s disease coupled with increasing efforts by market players to develop innovative solutions for Parkinson’s disease
  • Based on end use, the hospitals and ambulatory surgical centers segment dominated the market with the largest market share in 2023. This is due to the increasing adoption of advanced solutions in these facilities to enhance patient care and improve outcomes

The leading players in the Neuromodulation Devices market include:

  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Nexstim
  • LivaNova PLC
  • Neuropace Inc.
  • Nevro Corporation
  • electroCore, Inc.
  • Axonics, Inc.
  • Laborie

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Neuromodulation Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Government funding for research and development
3.2.1.2. Technological advancements in neuromodulation devices
3.2.1.3. Increasing prevalence of neurological disorders
3.2.1.4. Growing reimbursement coverage
3.2.1.5. Expanding applications
3.2.2. Market Restraints Analysis
3.2.2.1. Complex regulatory framework
3.2.2.2. Surgery-associated risk
3.3. Neuromodulation Devices Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. Neuromodulation Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Neuromodulation Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Global Neuromodulation Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Spinal Cord Stimulators
4.4.1. Spinal cord stimulators market revenue estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Deep Brain Stimulators
4.5.1. Deep brain stimulators market revenue estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Sacral Nerve Stimulators
4.6.1. Sacral nerve stimulators market revenue estimates and forecasts, 2018 - 2030 (USD Million)
4.7. Vagus Nerve Stimulators
4.7.1. Vagus nerve stimulators market revenue estimates and forecasts, 2018 - 2030 (USD Million)
4.8. Gastric Electrical Stimulation
4.8.1. Gastric electrical stimulation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
4.9. Others
4.9.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Neuromodulation Devices Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Neuromodulation Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Global Neuromodulation Devices Market Size & Trend Analysis, by Application 2018 to 2030 (USD Million)
5.4. Parkinson’s Disease
5.4.1. Parkinson’s disease market revenue estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Chronic Pain
5.5.1. Chronic pain market revenue estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Migraine
5.6.1. Migraine market revenue estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Epilepsy
5.7.1. Epilepsy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
5.8. Tremor
5.8.1. Tremor market revenue estimates and forecasts, 2018 - 2030 (USD Million)
5.9. Depression
5.9.1. Depression market revenue estimates and forecasts, 2018 - 2030 (USD Million)
5.10. Urinary & Fecal Incontinence
5.10.1. Urinary & fecal incontinence market revenue estimates and forecasts, 2018 - 2030 (USD Million)
5.11. Others
5.11.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Neuromodulation Devices Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Neuromodulation Devices Market: End use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Global Neuromodulation Devices Market Size & Trend Analysis, by End use 2018 to 2030 (USD Million)
6.4. Hospitals & Ambulatory Surgery Centers (ASC)
6.4.1. Hospitals & Ambulatory Surgery Centers (ASC) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Clinics & Physiotherapy Centers
6.5.1. Clinics & physiotherapy centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Neuromodulation Devices Market: Regional Estimates & Trend Analysis by Product, Application and End Use
7.1. Regional Dashboard
7.2. Market Size and Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. North America neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamics
7.3.2.2. Competitive scenario
7.3.2.3. Regulatory framework
7.3.2.4. Reimbursement scenario
7.3.2.5. U.S. neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamics
7.3.3.2. Competitive scenario
7.3.3.3. Regulatory framework
7.3.3.4. Reimbursement scenario
7.3.3.5. Canada neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key country dynamics
7.3.4.2. Competitive scenario
7.3.4.3. Regulatory framework
7.3.4.4. Reimbursement scenario
7.3.4.5. Mexico neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. Europe neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.2. U.K.
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Regulatory framework
7.4.2.4. Reimbursement scenario
7.4.2.5. U.K. neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Regulatory framework
7.4.3.4. Reimbursement scenario
7.4.3.5. Germany neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.4. France
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Regulatory framework
7.4.4.4. Reimbursement scenario
7.4.4.5. France neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamics
7.4.5.2. Competitive scenario
7.4.5.3. Regulatory framework
7.4.5.4. Reimbursement scenario
7.4.5.5. Italy neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamics
7.4.6.2. Competitive scenario
7.4.6.3. Regulatory framework
7.4.6.4. Reimbursement scenario
7.4.6.5. Spain neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Competitive scenario
7.4.7.3. Regulatory framework
7.4.7.4. Reimbursement scenario
7.4.7.5. Sweden neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Competitive scenario
7.4.8.3. Regulatory framework
7.4.8.4. Reimbursement scenario
7.4.8.5. Denmark neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.9. Norway
7.4.9.1. Key country dynamics
7.4.9.2. Competitive scenario
7.4.9.3. Regulatory framework
7.4.9.4. Reimbursement scenario
7.4.9.5. Norway neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement scenario
7.5.2.5. China neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.3. Japan
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Japan neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.4. India
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Regulatory framework
7.5.4.4. Reimbursement scenario
7.5.4.5. India neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Regulatory framework
7.5.5.4. Reimbursement scenario
7.5.5.5. South Korea neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.6. Australia
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Regulatory framework
7.5.6.4. Reimbursement scenario
7.5.6.5. Australia neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.7. Thailand
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Regulatory framework
7.5.7.4. Reimbursement scenario
7.5.7.5. Thailand neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Latin America neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Brazil neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. Argentina neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.7. Middle East and Africa
7.7.1. Middle East and Africa neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.2. South Africa
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. South Africa neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Saudi Arabia neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement scenario
7.7.4.5. UAE neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement scenario
7.7.5.5. Kuwait neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Market Share Analysis, 2023
8.4. Company Heat Map Analysis
8.5. Strategy Mapping
8.5.1. Expansion
8.5.2. Mergers & Acquisition
8.5.3. Partnerships & Collaborations
8.5.4. New Product Launches
8.5.5. Research And Development
8.5.6. Company Profiles
8.5.7. Abbott (St. Jude Medical)
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Medtronic
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Boston Scientific Corporation
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Aleva Neurotherapeutics
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic initiatives
8.5.11. Nexstim
8.5.11.1. Company overview
8.5.11.2. Financial performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic initiatives
8.5.12. LivaNova PLC
8.5.12.1. Company overview
8.5.12.2. Financial performance
8.5.12.3. Product Benchmarking
8.5.12.4. Strategic initiatives
8.5.13. Neuropace Inc.
8.5.13.1. Company overview
8.5.13.2. Financial performance
8.5.13.3. Product Benchmarking
8.5.13.4. Strategic initiatives
8.5.14. Nevro Corporation
8.5.14.1. Company overview
8.5.14.2. Financial performance
8.5.14.3. Product Benchmarking
8.5.14.4. Strategic initiatives
8.5.15. electroCore, Inc.
8.5.15.1. Company overview
8.5.15.2. Financial performance
8.5.15.3. Product Benchmarking
8.5.15.4. Strategic initiatives
8.5.16. Axonics, Inc.
8.5.16.1. Company overview
8.5.16.2. Financial performance
8.5.16.3. Product Benchmarking
8.5.16.4. Strategic initiatives
8.5.17. Laborie
8.5.17.1. Company overview
8.5.17.2. Financial performance
8.5.17.3. Product Benchmarking
8.5.17.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America neuromodulation devices market, by region, 2018 - 2030 (USD Million)
Table 3 North America neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 4 North America neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 5 North America neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 6 U.S. neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 9 Canada neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 10 Canada neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 11 Canada neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 12 Mexico neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 13 Mexico neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 14 Mexico neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 15 Europe neuromodulation devices market, by region, 2018 - 2030 (USD Million)
Table 16 Europe neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 17 Europe neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 18 Europe neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 19 Germany neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 20 Germany neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 21 Germany neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 22 UK neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 23 UK neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 24 UK neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 25 France neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 26 France neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 27 France neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 28 Italy neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 29 Italy neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 30 Italy neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 31 Spain neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 32 Spain neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 33 Spain neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 34 Denmark neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 35 Denmark neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 36 Denmark neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 37 Sweden neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 38 Sweden neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 39 Sweden neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 40 Norway neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 41 Norway neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 42 Norway neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific neuromodulation devices market, by region, 2018 - 2030 (USD Million)
Table 44 Asia Pacific neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 45 Asia Pacific neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 46 Asia Pacific neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 47 China neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 48 China neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 49 China neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 50 Japan neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 51 Japan neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 52 Japan neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 53 India neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 54 India neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 55 India neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 56 South Korea neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 57 South Korea neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 58 South Korea neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 59 Australia neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 60 Australia neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 61 Australia neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 62 Thailand neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 63 Thailand neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 64 Thailand neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 65 Latin America neuromodulation devices market, by region, 2018 - 2030 (USD Million)
Table 66 Latin America neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 67 Latin America neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 68 Latin America neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 69 Brazil neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 70 Brazil neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 71 Brazil neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 72 Argentina neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 73 Argentina neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 75 MEA neuromodulation devices market, by region, 2018 - 2030 (USD Million)
Table 76 MEA neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 77 MEA neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 78 MEA neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 79 South Africa neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 80 South Africa neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 85 UAE neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 86 UAE neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 87 UAE neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
Table 88 Kuwait neuromodulation devices market, by product, 2018 - 2030 (USD Million)
Table 89 Kuwait neuromodulation devices market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait neuromodulation devices market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig 1. Neuromodulation devices market segmentation
Fig 2. Market research process
Fig 3. Information procurement
Fig 4. Data analysis models
Fig 5. Market formulation and validation
Fig 6. Data validating & publishing.
Fig 7. Market snapshot
Fig 8. Segment snapshot.
Fig 9. Competitive landscape snapshot
Fig 10. Neuromodulation devices - market size and growth prospects (USD million)
Fig 11. Neuromodulation devices market: Industry Value Chain Analysis
Fig 12. Neuromodulation devices market: Market Dynamics
Fig 13. Neuromodulation devices market: PORTER’s Analysis
Fig 14. Neuromodulation devices market: PESTEL Analysis
Fig 15. Neuromodulation devices market share by product, 2023 & 2030 (USD Million)
Fig 16. Neuromodulation devices market, by product: market share, 2023 & 2030.
Fig 17. Spinal cord stimulators market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig 18. Deep brain stimulators market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig 19. Sacral nerve stimulators market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig 20. Vagus nerve stimulators market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig 21. Gastric electrical stimulation market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig 22. Others market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig 23. Neuromodulation devices market share by application, 2023 & 2030 (USD Million)
Fig 24. Neuromodulation devices market, by application: market share, 2023 & 2030.
Fig 25. Parkinson’s disease market share by application, 2023 & 2030 (USD Million)
Fig 26. Chronic Pain market share by application, 2023 & 2030 (USD Million)
Fig 27. Migraine market share by application, 2023 & 2030 (USD Million)
Fig 28. Epilepsy market share by application, 2023 & 2030 (USD Million)
Fig 29. Tremor market share by application, 2023 & 2030 (USD Million)
Fig 30. Depression market share by application, 2023 & 2030 (USD Million)
Fig 31. Urinary & fecal incontinence market share by application, 2023 & 2030 (USD Million)
Fig 32. Others market share by application, 2023 & 2030 (USD Million)
Fig 33. Neuromodulation devices market share by end use, 2023 & 2030 (USD Million)
Fig 34. Neuromodulation devices market, by end use: market share, 2023 & 2030.
Fig 35. Hospitals & Ambulatory Surgery Centers (ASC) market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig 36. Clinics & physiotherapy centers market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig 37. Others market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
Fig 38. Regional marketplace: key takeaways
Fig 39. North America neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 40. U.S. neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 41. Canada neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 42. Mexico neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 43. Europe neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 44. U.K. neuromodulation devices market estimates and forecasts, 2018 - 2030,) (USD Million)
Fig 45. Germany neuromodulation devices market estimates and forecasts (2018 - 2030,) (USD Million)
Fig 46. France neuromodulation devices market estimates and forecasts (2018 - 2030,) (USD Million)
Fig 47. Italy neuromodulation devices market estimates and forecasts (2018 - 2030,) (USD Million)
Fig 48. Spain neuromodulation devices market estimates and forecasts (2018 - 2030,) (USD Million)
Fig 49. Sweden neuromodulation devices market estimates and forecasts (2018 - 2030,) (USD Million)
Fig 50. Denmark neuromodulation devices market estimates and forecasts (2018 - 2030,) (USD Million)
Fig 51. Norway neuromodulation devices market estimates and forecasts (2018 - 2030,) (USD Million)
Fig 52. Asia Pacific neuromodulation devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig 53. China neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 54. Japan neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 55. India neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 56. South Korea neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 57. Australia neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 58. Thailand neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 59. Latin America neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 60. Brazil neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 61. Argentina neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 62. MEA neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 63. South Africa neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 64. Saudi Arabia neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 65. UAE neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 66. Kuwait neuromodulation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 67. Key company categorization
Fig 68. Company market positioning
Fig 69. Key company market share analysis, 2023
Fig 70. Strategic framework

Companies Mentioned

The leading players in the Neuromodulation Devices market include:
  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Nexstim
  • LivaNova PLC
  • Neuropace Inc.
  • Nevro Corporation
  • electroCore, Inc.
  • Axonics, Inc.
  • Laborie

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedSeptember 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 5.31 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.39 Billion
Compound Annual Growth Rate10.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Neuromodulation Devices Market by Product, Application, End User - Global Forecast 2025-2030 - Product Image

Neuromodulation Devices Market by Product, Application, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Neuromodulation Market by Technology, Application - Global Forecast 2025-2030 - Product Image

Neuromodulation Market by Technology, Application - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Neuromodulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Neuromodulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Neuromodulation Devices Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Biomaterial, and End User - Product Image

Neuromodulation Devices Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Biomaterial, and End User

  • Report
  • 150 Pages
  • Global
From
Neuromodulation Market by Type (Internal (Spinal Cord Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation), Application (Tremor, Epilepsy, Parkinson's Disease, Depression, Gastroparesis), and Region - Forecast to 2028 - Product Image

Neuromodulation Market by Type (Internal (Spinal Cord Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation), Application (Tremor, Epilepsy, Parkinson's Disease, Depression, Gastroparesis), and Region - Forecast to 2028

  • Report
  • 204 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.